COVID-19 transmission among vaccinated laboratory workers during the second wave in eastern Uttar Pradesh, India.
作者信息
Kumar Niraj, Misra Brij Ranjan, Reddy Mahendra M, Deval Hirawati, Zaman Kamran, Kant Rajni
机构信息
Indian Council of Medical Research-Regional Medical Research Centre Gorakhpur (ICMR-RMRC Gorakhpur), Gorakhpur, Uttar Pradesh, India.
出版信息
J Med Virol. 2022 Aug;94(8):3512-3514. doi: 10.1002/jmv.27788. Epub 2022 Apr 23.
Abstract
摘要
相似文献
1
COVID-19 transmission among vaccinated laboratory workers during the second wave in eastern Uttar Pradesh, India.印度北方邦东部第二波疫情期间接种疫苗的实验室工作人员中的新冠病毒传播情况。
J Med Virol. 2022 Aug;94(8):3512-3514. doi: 10.1002/jmv.27788. Epub 2022 Apr 23.
2
Differences in age distribution in first and second waves of COVID-19 in eastern Uttar Pradesh, India.印度北方邦东部地区 COVID-19 第一波和第二波的年龄分布差异。
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102327. doi: 10.1016/j.dsx.2021.102327. Epub 2021 Oct 30.
3
A preliminary study on contact tracing & transmission chain in a cluster of 17 cases of severe acute respiratory syndrome coronavirus 2 infection in Basti, Uttar Pradesh, India.印度北方邦巴斯蒂 17 例严重急性呼吸综合征冠状病毒 2 感染聚集性病例的接触者追踪和传播链初步研究。
Indian J Med Res. 2020;152(1 & 2):95-99. doi: 10.4103/ijmr.IJMR_2914_20.
4
Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India.新冠疫情第二波期间印度医护人员接种新冠疫苗的保护作用
Mayo Clin Proc. 2021 Sep;96(9):2493-2494. doi: 10.1016/j.mayocp.2021.06.003. Epub 2021 Jun 26.
5
Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.新冠病毒疫苗在预防感染和疾病严重程度方面的有效性：来自印度东部邦的一项病例对照研究。
Epidemiol Infect. 2021 Oct 11;149:e224. doi: 10.1017/S0950268821002247.
6
Accessing Antenatal Care (ANC) services during the COVID-19 first wave: insights into decision-making in rural India.在 COVID-19 第一波期间获取产前护理 (ANC) 服务：对印度农村决策的洞察。
Reprod Health. 2022 Jul 8;19(1):158. doi: 10.1186/s12978-022-01446-2.
7
Hesitancy and Acceptance of COVID-19 Vaccination Amidst the Second Wave of Pandemic in India: A General Population Study.印度第二波疫情期间新冠疫苗接种的犹豫与接受情况：一项普通人群研究
Asia Pac J Public Health. 2022 May;34(4):446-449. doi: 10.1177/10105395221077062. Epub 2022 Feb 8.
8
Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): A preliminary analysis from north India.在接种 ChAdOx1 nCoV-19 冠状病毒疫苗（重组）的优先人群中 COVID-19 的发生情况：来自印度北部的初步分析。
J Med Virol. 2022 Jan;94(1):407-412. doi: 10.1002/jmv.27320. Epub 2021 Sep 12.
9
Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.印度北方邦东部一家三级医疗机构的医护人员中，与Chadox1 nCOV-19冠状病毒疫苗（重组）相关的免疫接种后不良事件（AEFI）的发生率、模式和严重程度
Cureus. 2022 Feb 2;14(2):e21848. doi: 10.7759/cureus.21848. eCollection 2022 Feb.
10
Containment strategies for COVID-19 in India: lessons from the second wave.印度新冠肺炎疫情防控策略：第二波疫情的教训。
Expert Rev Anti Infect Ther. 2022 Jun;20(6):829-835. doi: 10.1080/14787210.2022.2036605. Epub 2022 Feb 7.
引用本文的文献
1
Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India.在印度北部第三波疫情期间，严重急性呼吸综合征冠状病毒2阳性病例中奥密克戎BA.2谱系占主导地位。
Front Med (Lausanne). 2022 Nov 2;9:955930. doi: 10.3389/fmed.2022.955930. eCollection 2022.
Zotero 插件